Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis

KEY POINTS: P2Y12 inhibitor monotherapy after 1–3 months of dual antiplatelet therapy (DAPT) decreases the risk of clinically significant bleeding when compared with 12 months of DAPT in patients with CKD treated with a drug-eluting stent. There is no significant difference in the risk of cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Festa, Maria Carolina, Rasasingam, Sathiepan, Sharma, Abhinav, Mavrakanas, Thomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547225/
https://www.ncbi.nlm.nih.gov/pubmed/37768893
http://dx.doi.org/10.34067/KID.0000000000000223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547225/
https://www.ncbi.nlm.nih.gov/pubmed/37768893
http://dx.doi.org/10.34067/KID.0000000000000223

Ejemplares similares